Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.1 (
protein kinase
)
81,284
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have identified a new functional transmembrane receptor,
LRRC19
(leucine-rich repeat containing 19), that belongs to the LRR protein family.
LRRC19
's central core has four analogous LRR repeating modules in a juxtaposed array and a
casein kinase
(CK2) phosphorylation site in the cytoplasmic domain.
LRRC19
mRNA was found in the kidney, spleen and intestine of adult mice using both RT-PCR and in situ hybridization.
LRRC19
does not contain a cytoplasmic Toll/IL-1 receptor (TIR) domain but was able to activate NF-kappaB and induce production of proinflammatory cytokines.
LRRC19
shares a close evolutionary relationship with multiple Toll-like receptors (TLRs), especially TLR3. Importantly, the TLR3 ligand, as well as other TLR ligands, significantly promoted the expression of proinflammatory cytokines and the activation of NF-kappaB by
LRRC19
. Thus,
LRRC19
may play an important role in inducing innate immune responses in certain tissues such as the kidney.
...
PMID:LRRC19, a novel member of the leucine-rich repeat protein family, activates NF-kappaB and induces expression of proinflammatory cytokines. 1967 3